Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens II. Further analysis of mammalian cell results, relative predictivity and tumour profiles.

One of the consequences of the low specificity of the in vitro mammalian cell genotoxicity assays reported in our previous paper [D. Kirkland, M. Aardema, L. Henderson, L. Muller, Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens. I. Sensitivity, specificity and relative predictivity, Mutat. Res. 584 (2005) 1-256] is industry and regulatory agencies dealing with a large number of false-positive results during the safety assessment of new chemicals and drugs. Addressing positive results from in vitro genotoxicity assays to determine which are "false" requires extensive resources, including the conduct of additional animal studies. In order to reduce animal usage, and to conserve industry and regulatory agency resources, we thought it was important to raise the question as to whether the protocol requirements for a valid in vitro assay or the criteria for a positive result could be changed in order to increase specificity without a significant loss in sensitivity of these tests. We therefore analysed some results of the mouse lymphoma assay (MLA) and the chromosomal aberration (CA) test obtained for rodent carcinogens and non-carcinogens in more detail. For a number of chemicals that are positive only in either of these mammalian cell tests (i.e. negative in the Ames test) there was no correlation between rodent carcinogenicity and level of toxicity (we could not analyse this for the CA test as insufficient data were available in publications), magnitude of response or lowest effective positive concentration. On the basis of very limited in vitro and in vivo data, we could also find no correlation between the above parameters and formation of DNA adducts. Therefore, a change to the current criteria for required level of toxicity in the MLA, to limit positive calls to certain magnitudes of response, or to certain concentration ranges would not improve the specificity of the tests without significantly reducing the sensitivity. We also investigated a possible correlation between tumour profile (trans-species, trans-sex and multi-site versus single-species, single-sex and single-site) and pattern of genotoxicity results. Carcinogens showing the combination of trans-species, trans-sex and multi-site tumour profile were much more prevalent (70% more) in the group of chemicals giving positive results in all three in vitro assays than amongst those giving all negative results. However, single-species, single-sex, single-site carcinogens were not very prevalent even amongst those chemicals giving three negative results in vitro. Surprisingly, when mixed positive and negative results were compared, multi-site carcinogens were highly prevalent amongst chemicals giving only a single positive result in the battery of three in vitro tests. Finally we extended our relative predictivity (RP) calculations to combinations of positive and negative results in the genotoxicity battery. For two out of three tests positive, the RP for carcinogenicity was no higher than 1.0 and for 2/3 tests negative the RP for non-carcinogenicity was either zero (for Ames+MLA+MN) or 1.7 (for Ames+MLA+CA). Thus, all values were less than a meaningful RP of two, and indicate that it is not possible to predict outcome of the rodent carcinogenicity study when only 2/3 genotoxicity results are in agreement.

[1]  M. Dolan,et al.  Studies of the repair of O6-alkylguanine and O4-alkylthymine in DNA by alkyltransferases from mammalian cells and bacteria. , 1985, Environmental health perspectives.

[2]  F. Granath,et al.  Studies on the relationship between hemoglobin and DNA adducts of malonaldehyde and their stability in vivo. , 1993, Carcinogenesis.

[3]  G. Cantelli-forti,et al.  Isolation of a novel metabolizing system enriched in phase-II enzymes for short-term genotoxicity bioassays. , 1998, Mutation research.

[4]  G. Keith,et al.  Detection of DNA adducts in declining hop plants grown on fields formerly treated with heptachlor, a persistent insecticide. , 1995, Environmental pollution.

[5]  P. Bentley,et al.  Species differences in the covalent binding of p-chloro-o-toluidine to DNA. , 1986, Archives of toxicology. Supplement. = Archiv fur Toxikologie. Supplement.

[6]  D. Roy,et al.  In vivo DNA adduct formation by bisphenol A , 1995, Environmental and molecular mutagenesis.

[7]  Haifang Wang,et al.  Binding of nitrobenzene to hepatic DNA and hemoglobin at low doses in mice. , 2003, Toxicology letters.

[8]  J. Chipman,et al.  Chloroform, carbon tetrachloride and glutathione depletion induce secondary genotoxicity in liver cells via oxidative stress. , 2003, Toxicology.

[9]  M M Moore,et al.  The L5178Y/tk+/- mouse lymphoma specific gene and chromosomal mutation assay a phase III report of the U.S. Environmental Protection Agency Gene-Tox Program. , 1997, Mutation research.

[10]  E. Zeiger,et al.  Handbook of Carcinogenic Potency and Genotoxicity Databases , 1996 .

[11]  A. J. Gandolfi,et al.  Microsomal bioactivation and covalent binding of aliphatic halides to DNA. , 1982, Toxicology letters.

[12]  David Kirkland,et al.  Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens III. Appropriate follow-up testing in vivo. , 2005, Mutation research.

[13]  K. Randerath,et al.  32P-postlabeling of 1,3-butadiene and 4-vinyl-1-cyclohexene metabolite-DNA adducts: in vitro and in vivo applications. , 1996, Toxicology.

[14]  P. Farmer,et al.  Genotoxicity of the benzene metabolites para-benzoquinone and hydroquinone. , 2005, Chemico-biological interactions.

[15]  L. Chekir‐Ghedira,et al.  Genotoxicity of zearalenone, an estrogenic mycotoxin: DNA adduct formation in female mouse tissues. , 1995, Carcinogenesis.

[16]  R. Bull,et al.  Lipid peroxidation and formation of 8-hydroxydeoxyguanosine from acute doses of halogenated acetic acids. , 1996, Fundamental and applied toxicology : official journal of the Society of Toxicology.

[17]  L. Fong,et al.  DNA methyl-adduct dosimetry and O6-alkylguanine-DNA alkyl transferase activity determinations in rat mammary carcinogenesis by procarbazine and N-methylnitrosourea. , 1990, Carcinogenesis.

[18]  S. Warren,et al.  Atrazine treatment potentiates excretion of mutagenic urine in 2, 6‐dinitrotoluene‐treated fischer 344 rats , 1995, Environmental and molecular mutagenesis.

[19]  W. Bodell,et al.  Formation of DNA adducts in HL-60 cells treated with the toluene metabolite p-cresol: a potential biomarker for toluene exposure. , 2003, Chemico-biological interactions.

[20]  M. Steenwinkel,et al.  DNA damage and mutagenesis induced by procarbazine in lambda lacZ transgenic mice: evidence that bone marrow mutations do not arise primarily through miscoding by O6-methylguanine. , 1997, Carcinogenesis.

[21]  J. Barrett,et al.  Bisphenol‐A induces cellular transformation, aneuploidy and DNA adduct formation in cultured Syrian hamster embryo cells , 1998, International journal of cancer.

[22]  Robert A Beckman,et al.  Genetic instability in cancer: theory and experiment. , 2005, Seminars in cancer biology.

[23]  Isao Yoshimura,et al.  Mouse lymphoma thymidine kinase gene mutation assay: Follow‐up meeting of the international workshop on Genotoxicity testing—Aberdeen, Scotland, 2003—Assay acceptance criteria, positive controls, and data evaluation , 2006, Environmental and molecular mutagenesis.

[24]  M. Casanova,et al.  Lack of evidence for the involvement of formaldehyde in the hepatocarcinogenicity of methyl tertiary-butyl ether in CD-1 mice. , 1997, Chemico-biological interactions.

[25]  Lutz Müller,et al.  Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens I. Sensitivity, specificity and relative predictivity. , 2005, Mutation research.